Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spectral AIMDAI 6 Receivables Turnover is 3.26 as of Mar. 2026. GuruFocus rates MDAI with a GF Score™ of 6/100 and a GF Value™ of $0.86 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Spectral AI ranks better than 91.49% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Spectral AI's Revenue for the
three
months ended in Mar. 2026 was $3.99 Mil. Spectral AI's average Accounts Receivable for the
three
months ended in Mar. 2026 was $1.23 Mil.
Hence, Spectral AI's Receivables Turnover for the
three
months ended in Mar. 2026 was 3.26.
Spectral AI (NAS:MDAI) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Spectral AI Receivables Turnover Related Terms
Spectral AI Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Spectral AI's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDAI vs LUNG, QTI, COCH: Receivables Turnover Comparison
For the Medical Devices subindustry, Spectral AI's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spectral AI Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Spectral AI's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spectral AI (MDAI) has a Receivables Turnover of 3.26 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Spectral AI and its competitors. According to the industry distribution chart, Spectral AI ranks #69 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 8.5%.
Is Spectral AI's Receivables Turnover too high?
Spectral AI's current Receivables Turnover is 3.26. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Spectral AI's value of 3.26 is 40.8% below this industry median. Based on the distribution chart, Spectral AI ranks #69 out of 811 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Spectral AI has a GF Score™ of 6/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Spectral AI's Receivables Turnover compare to LUNG and QTI?
According to the Medical Devices & Instruments industry distribution chart, Spectral AI ranks #69 out of 811 companies for Receivables Turnover. This places Spectral AI in the top 9% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.51. Spectral AI's value of 3.26 is 40.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spectral AI's current Receivables Turnover of 3.26 is 40.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Spectral AI and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spectral AI's current Receivables Turnover is 3.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spectral AI stock overvalued right now?
Based on GuruFocus' analysis, Spectral AI (MDAI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.86, compared to a current price of $1.64 — trading 90.7% above its estimated fair value. The current Receivables Turnover is 3.26 and 40.8% below the Medical Devices & Instruments industry median of 5.51. Spectral AI's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Spectral AI (MDAI), the current Receivables Turnover is 3.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spectral AI (MDAI) Overvalued in 2026?
Based on GuruFocus' analysis, Spectral AI stock appears to be overvalued.
The current stock price of $1.64 is trading 90.7% above its estimated GF Value™ of $0.86.
GuruFocus considers Spectral AI to be Significantly Overvalued.
Key valuation signals for MDAI:
Receivables Turnover: 3.26
GF Value™: $0.86 vs. price of $1.64 (90.7% above fair value)
Industry Position: 40.8% below the Medical Devices & Instruments median (#69 of 811)
No single metric tells the full story. See the MDAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
6GF Score
Get the complete analysis for MDAI
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDAI has been successfully added to your 
